ClinicalTrials.govpublic full text
Galantamine Effects in Patients With Metabolic Syndrome
abdominal obesity metabolic syndrome, cholinergic antagonists, inflammation, oxidative stress, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913652
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.